Anastrozole is cost-effective vs tamoxifen as initial adjuvant therapy in early breast cancer: Canadian perspectives on the ATAC completed-treatment analysis.

v1

Type:Journal Article

0 views

[![NobleID](https://www.nobleid.org/api/badge/511D7FDA.svg?ark=w1%2F20260515%2F511D7FDA)](https://nobleid.org/work/w1/20260515/511D7FDA)

ARK Inflections

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors